Literature DB >> 29285723

The Divalent Elements Changes in Early Stages of Chronic Kidney Disease.

Wan-Ju Kung1, Ching-Tang Shih2, Chien-Hung Lee3, Ching-Chiang Lin4,5.   

Abstract

As the glomerular filtration rate (GFR) decreases, it can cause imbalance in some divalent elements. These imbalances can cause increased oxidative stress in patients with renal impairment. The aim of present study was to investigate the changes of these divalent elements with CKD progression. One hundred and ninety-four patients with chronic kidney diseases (CKD) were divided into five stages, stage 1, 2, 3a, 3b, 4, and were recruited into this study. The divalent elements, calcium, magnesium, phosphorus, as well as iron, zinc, and copper were determined in clinical chemistry analyzer. Higher CKD stages were found to be associated with increased levels of phosphorus and copper; Ptrend values were 0.002 and 0.004, respectively. Also, higher CKD stages were associated with decreased levels of zinc; Ptrend value was 0.002, after adjustment for age, gender, smoke, education, diabetes, hypertension, and BMI. Decreased levels of zinc and elevated levels of phosphorus and copper might increase the oxidative stress and complications in CKD patients. Future randomized studies are needed to show whether adjusting dietary intake of phosphorus, copper, and zinc might affect the progression of CKD.

Entities:  

Keywords:  Chronic kidney disease; Copper; Divalent element; Iron; Magnesium; Trace element; Zinc

Mesh:

Substances:

Year:  2017        PMID: 29285723     DOI: 10.1007/s12011-017-1228-3

Source DB:  PubMed          Journal:  Biol Trace Elem Res        ISSN: 0163-4984            Impact factor:   3.738


  1 in total

1.  Environment-Based Impairment in Mineral Nutrient Status and Heavy Metal Contents of Commonly Consumed Leafy Vegetables Marketed in Kyrgyzstan: a Case Study for Health Risk Assessment.

Authors:  Hasan Can; Ibrahim Ilker Ozyigit; Merve Can; Asli Hocaoglu-Ozyigit; Ibrahim Ertugrul Yalcin
Journal:  Biol Trace Elem Res       Date:  2020-06-17       Impact factor: 3.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.